Abstract: FR-PO099
Multifaceted Role of ST2/IL-33 Axis During Kidney Injury
Session Information
- AKI: Mechanisms - Inflammation/Sepsis/Remote Injury
November 08, 2019 | Location: Exhibit Hall, Walter E. Washington Convention Center
Abstract Time: 10:00 AM - 12:00 PM
Category: Acute Kidney Injury
- 103 AKI: Mechanisms
Authors
- Sabapathy, Vikram, Division of Nephrology and CIIR, Charlottesville, Virginia, United States
- Venkatadri, Rajkumar, Division of Nephrology and CIIR, Charlottesville, Virginia, United States
- Dogan, Murat, Division of Nephrology and CIIR, Charlottesville, Virginia, United States
- Mohammad, Saleh, Division of Nephrology and CIIR, Charlottesville, Virginia, United States
- Cheru, Nardos Tesfaye, National Institutes of Health, Bethesda, Maryland, United States
- Price, Airi, Division of Nephrology and CIIR, Charlottesville, Virginia, United States
- Stevens, Brian K., Division of Nephrology and CIIR, Charlottesville, Virginia, United States
- Sharma, Rahul, Division of Nephrology and CIIR, Charlottesville, Virginia, United States
Background
Renal diseases are a major cause of morbidity and mortality. Inflammation elicited by variety of cytokines and chemokines are a major player in initiation and progression of the disease. Interleukin 33 (IL-33) belongs to IL-1 family of cytokines, which was identified for eliciting T helper-2 (Th2) cytokines. IL-33 acts as an ‘alarmin’ that regulates the immune response during injury. IL-33 acts in an autocrine/paracrine manner on the ST2 membrane receptor IL33R or Il1rl1, triggering innate and adaptive immune response. ST2 is widely expressed in immune cells including regulatory T cells (Tregs). Importance of ST2/IL-33 signaling in Tregs has been demonstrated in multiple inflammatory conditions. However, cell specific contribution of ST2/IL33 signaling is not understood. Here, we investigated the cell specific ST2/IL33 signaling activity using murine renal injury models.
Methods
Murine ischemia-reperfusion injury (IRI) model was used to investigate cell specific ST2/IL-33 signaling using IL1RL1tm1a and cell specific Pepck, Foxd1 and Foxp3 -cre mice to delete ST2 expression in proximal tubular cells (PTC), pericytes and Tregs respectively. The structure and function of the kidney were probed using flow cytometry, histology, immunohistochemistry, qRT-PCR and biochemical analysis.
Results
In vivo experimental data indicated that deletion of ST2 in PTC and pericytes attenuated renal injury suggesting that activation of ST2/IL33 signaling in these cells leads to impaired renal function following IRI, leading to fibrosis. On the contrary, elimination of ST2/IL33 signaling from Tregs resulted in greater renal injury to the indicating that activation of ST2/IL33 signaling in Tregs mediate renal protection during inflammation and injury.
Conclusion
This study addresses the cell specific role of ST2/IL33 signaling in immune-regulation, fibrosis and repair. Our findings try to delineate the multifaceted role of ST2/IL33 axis in renal injury. We conclude modulation of ST2/IL33 siganling as a promising therapeutic option.
IL33/ST2 Signaling is a Double Edge Sword
Funding
- NIDDK Support